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Two integral membrane proteins, Patched and
Smoothened, were for a long time thought to com-
prise a preformed receptor complex for secreted
Hedgehog signalling proteins. Recent analyses of
the subcellular distribution of these proteins argue
strongly against this simple model.
Signalling proteins of the Hedgehog (Hh) family are
essential for patterning and morphogenesis in most
multicellular organisms [1]. Reception of the Hh signal
at the cell surface requires the activity of two trans-
membrane proteins. Patched (Ptc) is a polytopic
protein predicted to contain twelve transmembrane
domains and binds directly to Hh proteins and inhibits
the activity of a second component of the receptor
complex, Smoothened (Smo). Smo is a seven-pass
membrane protein that is required to transduce the Hh
signal. In the absence of Ptc, Smo activity is indepen-
dent of the Hh ligand and constitutively activates the
Hh signalling pathway [2]. Thus the binding of Hh to
Ptc is thought to liberate Smo from repression by Ptc.
A simple model had been proposed whereby Ptc
inhibits Smo via a direct, stable, physical interaction,
and Hh binding to Ptc causes a conformational change
in this Ptc–Smo receptor complex which frees Smo
from inhibition. A number of recent studies, including
one in this issue of Current Biology, put forward com-
pelling arguments against this model [3–7].
A Ptc–Smo Complex
Two key papers [8,9] showed that epitope-tagged ver-
tebrate homologues of Ptc and Smo could be coim-
munoprecipitated from cells expressing them at high
levels, in the presence and absence of a Hh signal,
and that a trimeric complex of Ptc–Smo–Hh could be
detected after cell-surface crosslinking [8]. Although
significant levels of the bimolecular complex were
present in cells in which a Hh reporter gene was strongly
activated, these results did not decisively show the
composition of the active receptor complex. It was
proposed that Hh binding might evoke dissociation of
a preformed Ptc–Smo complex freeing active Smo, or
a conformational change within the stable complex to
activate Smo.
To understand how the activities of Ptc and Smo
are regulated by Hh, recent studies have addressed
the distribution of Hh, Ptc and Smo in cultured
Drosophila cells, as well as in vivo. [3–5,7]. These
studies present evidence that Smo protein is not
present in a complex bound to Ptc and suggest that in
the absence of Hh, Ptc indirectly modifies Smo protein
to generate an inactive moiety, in a non-stochiometric
reaction [4,5].
Where are Ptc and Smo?
A key observation is that Smo protein levels increase
dramatically in cells responding to Hh. Denef and col-
leagues [4] looked in detail at the subcellular distribu-
tion of Smo and Ptc in cultured Drosophila cells and in
the cells of larval wing discs. Their results produced
two further conclusions: that the binding of Hh to Ptc
at the cell surface leads to the removal of Ptc protein
from the plasma membrane; and that the activation of
the Hh signal transduction pathway triggers the phos-
phorylation of Smo concomitant with a dramatic
increase in Smo at the cell surface. In a parsimonious
interpretation of their data, the authors invoke a require-
ment for at least an additional kinase/phosphatase
module in the transduction pathway. Thus, in the
absence of Hh, Ptc’s constitutive inhibitory activity
might be mediated by the action of a phosphatase to
counter the constitutive phosphorylation of Smo
protein by an appropriate kinase.
A Putative Role for Intracellular Trafficking
Ptc protein contains a so-called sterol-sensing domain
(SSD), a motif found in proteins that regulate choles-
terol metabolism, and the sorting and recycling of
cholesterol and glycosphingolipids in the late endo-
some–lysosome system [10]. In addition, it is possible
to block both the response of cells to Hh and the intra-
cellular transport of cholesterol by a number of com-
pounds including the plant steroidal alkaloids cyclop-
amine and jervine [11]. However, cells expressing
mutant forms of NPC1 that block cholesterol transport
do not have a diminished response to Hh signalling
[12], suggesting that these compounds instead affect
a vesicular transport route that is shared by Hh sig-
nalling components and cholesterol transport.
A more recent study in the mouse [13] has shown
that mutations in the Ras-like GTPase Rab23, impor-
tant for vesicle fusion during endocytosis and exocy-
tosis, inhibit Hh signalling in the developing neural
tube. These mutations appear to lead to the ligand-
independent activation of the Hh pathway, further
emphasising the role of intracellular trafficking in the
response to Hh. Together these data strongly suggest
that the intracellular trafficking of Ptc and Smo
through the late endosome–lysosome system is
pivotal for regulation of the Hh signalling pathway.
Subcellular Localisation of Ptc
In two Current Biology papers published last year, the
Ingham [5] and Guerrero [6] labs published detailed
mutational analyses of the mechanism by which Ptc
regulates Smo activity. Ingham and colleagues [5]
described the subcellular distributions of Ptc and Hh
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in embryos homozygous for a number of Ptc loss-of-
function mutations whose sequence was already
known, or determined by this group. The authors con-
firmed the accumulation of wild-type Ptc in multi-
vesicular bodies and endosomes, and showed that
some of these vesicles contain Hh. Importantly, even
cells some distance from a source of Hh also con-
tained punctate accumulations of Ptc protein, sug-
gesting that Ptc cycles between endosomes and the
cell surface even in the absence of Hh. Of the Ptc
mutants used in this study, three were distributed sim-
ilarly to the wild-type protein and, strikingly, they colo-
calised with Hh protein in a punctate distribution. Thus
these mutant proteins appear to bind and endocytose
Hh protein, yet fail to inhibit Smo activity.
Ptc’s SSD: Hh Sequestration and Smo Inhibition
Interestingly, two of these three mutations affected
the SSD of Ptc. In the study by the Guerrero lab [6], a
Ptc mutant was engineered to contain a single amino
acid substitution in the SSD. The mutation behaved as
a strong loss-of-function allele, yet the distribution of
the mutant protein was unaffected by this change; nor
did it alter the ability of Ptc to bind and sequester Hh.
As noted above, the occurrence of an SSD in Ptc has
been argued by some to support a role for the protein
in interacting in some way with cholesterol. However,
it has been far from clear whether this cholesterol is,
for example, the moiety added to the active amino-
terminal fragment of Hh during its biogenesis or the
cholesterol of putative lipid microdomains in specific
vesicles such as late endosomes which might be
important for targeting Ptc for degradation [4,10].
In light of the data suggesting that Ptc regulates
Smo activity by affecting its post-translational modifi-
cation or stability, Ingham and colleagues [5] and
Guerrero and colleagues [6] both suggest that the
SSD plays a pivotal role in the ability of Ptc to regulate
Smo. And Ingham and colleagues suggest that Ptc
might be acting in a similar manner to other SSD-con-
taining proteins, such as SCAP and NPC1, to regulate
the intracellular trafficking of Smo to a compartment
where it is targeted for modification or degradation.
Ptc and Smo Co-internalisation
In this issue of Current Biology, Roelink and col-
leagues [3] present the most detailed analysis to 
date of the subcellular localisation of Ptc and Smo
and show how this distribution is affected by a Hh
ligand. The authors generated lines of KNRK cells
stably expressing epitope-tagged vertebrate homo-
logues of Ptc and Smo, alone and in combination.
Their results clearly show by confocal microscopy
that, when expressed in the absence of Smo, Ptc is
constitutively internalised and degraded in lysosomes.
Internalisation of Ptc is significantly increased when
these cells are exposed to the biologically active
amino-terminal fragment of Sonic hedgehog (Shh).
When Ptc and Smo are expressed together in the
same cells, reflecting more closely the physiological
scenario, in the absence of Shh, the rate of Ptc inter-
nalisation is greatly reduced. Furthermore, Ptc and
Smo can be seen to be internalised together and enter
the endosomal pathway, albeit relatively slowly, and
are degraded in lysosomes.
Hh Induces Segregation of Ptc and Smo
Exposure of cells expressing Ptc and Smo to Shh
leads to the co-internalisation of Ptc, Smo and Shh,
but now only Ptc and Shh are degraded in lysosomes.
The authors show that, after entering late endosomes
together, Smo is somehow segregated from the
Ptc–Shh complex, and is now presumably free to
signal and return to the cell surface. The accumulation
of Smo at the cell surface in response to Shh protein
is reported here, confirming similar data from previous
studies [4,6]. In support of this late endosome segre-
gation model, the authors also show that antibodies to
the late-endosome-specific lipid lysobisphosphatidic
acid (LBPA), an endosomal membrane component
essential for endosome structure and function, are
able to interfere with the segregation of Ptc and Smo
and inhibit activation of the pathway.
Importantly, these antibodies will also inhibit Shh
signalling in chick neural plate explants, suggesting
that the intracellular movement of Ptc and Smo in
these KRNK cell lines is physiologically meaningful. In
addition the authors look at the distribution of consti-
tutively active mutant Smo proteins, previously iso-
lated from sporadic basal cell carcinomas [14] that are
not inhibited by Ptc protein [9]. The distribution of
these mutant proteins, M2 and to a lesser extent M1,
is consistent with them failing to colocalise and coin-
ternalise with Ptc. Hence the Hh-dependent segrega-
tion of these molecules from Ptc is circumvented and
the pathway is activated independently of a Hh signal.
Do Ptc and Smo Interact Directly?
The results of Roelink and colleagues [3] illustrate the
dynamic nature of Ptc and Smo localisation, and high-
light the intimate relationship of these proteins through-
out most compartments. One significant result that
Roelink and others (for example [7]) have failed to
confirm is the coimmunoprecipitation of Ptc and Smo.
The idea of a preformed receptor complex comprising
Smo and Ptc was an attractive, mechanistically simple
interpretation of the early genetic analyses of Ptc and
Smo function, supported by limited biochemical data.
However, these early studies used transiently trans-
fected cells expressing very high levels of protein. And
although epitope-tagged molecules were expressed,
the forms of Smo protein detected by subsequent
western blotting ran at unusually high molecular
weights. Subsequent studies mimicking more physio-
logical conditions have failed to detect a stable
Ptc–Smo complex, and no study has shown such a
complex to be present in vivo.
Future Directions
The results of Roelink et al. [3] clearly strengthen
support for the model whereby Ptc indirectly regulates
Smo activity; a key event is the segregation of 
Smo from ‘activated’ Ptc in late endosomes. However,
these results raise a number of questions. Why is 
Smo transported into the late endocytic pathway
along with Ptc? How does Hh binding to Ptc trigger
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the segregation of Smo? Why should SSD mutants of
Ptc behave as dominant-negative molecules [5,6]?
And at a more basic level, just what is the physiologi-
cal relevance of activated Smo being transported to
the cell surface?
Resolving the mysteries over the missing biological
activities of these molecules is a priority. Is Smo a G-
protein coupled receptor (see for example [15,16])? Is
Ptc a transmembrane permease like NPC1 (see
[10,17])? And of course, tracking down the putative
missing components of the pathway might also help
provide some eagerly awaited answers.
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